Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial경증/중등도의 COVID-19 성인 환자에 대한 로피나비르/리토나비르 또는 아르비돌의 효능 및 안전성: 탐색적 무작위 대조 시험Randomized Controlled Trial Published on 2020-05-192022-09-14 Journal: Med (New York, N.Y.) [Category] [DOI] 10.1016/j.medj.2020.04.001 PMC 바로가기 [Article Type] Randomized Controlled Trial
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation?Article Published on 2019-04-012023-06-16 Journal: Infection [Category] [DOI] 10.1007/s15010-019-01271-z PMC 바로가기
Next generation sequencing of HIV-1 protease in the PIVOT trial of protease inhibitor monotherapy프로테아제 억제제 단독 요법의 PIVOT 시험에서 HIV-1 프로테아제의 차세대 시퀀싱Article Published on 2018-04-012022-09-06 Journal: Journal of Clinical Virology [Category] [DOI] 10.1016/j.jcv.2018.02.003 PMC 바로가기 [Article Type] Article
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialHIV의 2차 치료를 위한 로피나비르 + 뉴클레오시드 역전사효소 억제제, 로피나비르 + 랄테그라비르 또는 로피나비르 단독요법(EARNEST): 무작위 대조 시험의 144주 추적 결과Article Published on 2018-01-012022-09-06 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(17)30630-8 PMC 바로가기 [Article Type] Article
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial공중 보건 접근법에서 뉴클레오시드 역전사효소 억제제 교차 내성 및 2차 항레트로바이러스 요법의 결과: 무작위, 공개, EARNEST 시험 내 관찰 분석Articles Published on 2017-05-082022-09-06 Journal: The Lancet. HIV [Category] [DOI] 10.1016/S2352-3018(17)30065-6 PMC 바로가기 [Article Type] Articles
Management of Antiviral Resistance in Chronic Hepatitis BReview Published on 2017-03-152023-06-19 Journal: Gut and liver [Category] [DOI] 10.5009/gnl15562 PMC 바로가기 [Article Type] Review
Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trialHIV 감염의 장기 관리를 위한 프로테아제 억제제 단독 요법: 무작위, 대조, 공개, 비열등성 시험Articles Published on 2015-09-142022-09-06 Journal: The Lancet. HIV [Category] [DOI] 10.1016/S2352-3018(15)00176-9 PMC 바로가기 [Article Type] Articles
Lipid lowering efficacy and safety of Ezetimibe combined with rosuvastatin compared with titrating rosuvastatin monotherapy in HIV-positive patientsHIV 양성 환자에서 로수바스타틴 적정 단독요법과 비교한 에제티미브와 로수바스타틴 병용요법의 지질강하 효능 및 안전성Research Published on 2015-06-192022-09-06 Journal: Lipids in Health and Disease [Category] [DOI] 10.1186/s12944-015-0054-x PMC 바로가기 [Article Type] Research